Advisory Services Network, LLC Fibrogen Inc Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$10.18 - $26.64 $20,360 - $53,280	-2,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$18.57 - $35.68 $37,140 - $71,360	2,000 New	2,000 $53,000
Q1 2021 May 24, 2021	SELL	$31.0 - $55.72 $279 - $501	-9 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$37.09 - $48.97 $4,487 - $5,925	-121 Reduced 93.08%	9 $0
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $5,261 - $5,915	130 New	130 $5,000
Q2 2020 Aug 10, 2020	SELL	$32.57 - $42.83 $293 - $385	-9 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$34.58 - $48.06 $311 - $432	9 New	9 $0

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.